论文信息 - Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics. - 字舞流文

Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics.

G. Wolf | Gunter Wolf

[1] Bertram Pitt,et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.

[2] R. Largo,et al. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. , 1996, Hypertension.

[3] C. Johnston,et al. Angiotensin receptor antagonists: focus on losartan , 1995, The Lancet.

[4] R. Harris,et al. Angiotensin actions in the kidney: renewed insight into the old hormone. , 1991, Kidney international.

[5] J. Norman,et al. The role of angiotensin II in renal growth. , 1991, Renal physiology and biochemistry.

[6] A. Katz,et al. Angiotensin II: hemodynamic regulator or growth factor? , 1990, Journal of molecular and cellular cardiology.

[7] Y. S. Bakhle,et al. Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung , 1968, Nature.